Results 271 to 280 of about 1,835,166 (363)

Serum free light chain concentration and ratio‐based criterion for myeloma‐defining event, in its current version, is untenable

British Journal of Haematology, EarlyView.
Summary Clinical decision‐making based on myeloma‐defining event criteria using thresholds for involved serum free light chain level of 10 mg/dL and ratio of involved to uninvolved light chain of >100 is a poor indicator for the risk of progression to multiple myeloma.
Gurmukh Singh
wiley   +1 more source

Anti-GD1b Disorder Presenting as Multiple Mononeuropathies. [PDF]

Clin Case Rep
Eid K, Araoui R, Ismail R, Sawaya R.
europepmc   +1 more source

MRD‐negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD‐positive after first‐line therapy: Final analysis of the open‐label, single‐arm multicentric phase 2 trial DART4MM

British Journal of Haematology, EarlyView.
In newly diagnosed multiple myeloma patients in ≥Very Good Partial Remission (VGPR) after a first‐line therapy daratumumab as consolidation/maintenance improved long‐term minimal residual disease negativity. Summary Daratumumab is approved for front‐line and relapsed myeloma therapy.
Alessandro Gozzetti, Paola Pacelli, Federico Caroni, Donatella Raspadori, Elena Bestoso, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Adele Santoni, Luca Puccetti, Francesca Bacchiarri, Ludovica Pengue, Dania Tocci, Irene Attucci, Maria Livia del Giudice, Miriana Ruggieri, Alessandra Lombardo, Anna Marina Liberati, Veronica Candi, Vincenzo Sammartano, Alessandra Cartocci, Anna Sicuranza, Sara Galimberti, Alessandro Maria Vannucchi, Monica Bocchia   +24 more
wiley   +1 more source

Curcuma longa improves endothelial glycocalyx integrity and redox-inflammatory pathways in type 2 diabetes mellitus: a randomized double-blind placebo-controlled study. [PDF]

Eur J Nutr
Viudes DR, Mateus AR, Silva CA, do Carmo Franco M.   +3 more
europepmc   +1 more source

Neurophysiological Characteristics of Upper Extremity Neuropathy in Three Young Patients with Mucopolysaccharidosis Type I and II in a Five-Year Observation-A Case Series Study. [PDF]

Neurol Int
Wiertel-Krawczuk A, Krawczuk Z, Huber J.
europepmc   +1 more source

Brachial Artery Pseudoaneurysm Presenting as Median Nerve Neuropathy

Gorentla Narasimha Sai, Naveen Venkat, K. Athirath Reddy, Guladurti Sudharshan, Sandeep Mahapatra, Anusha Arumalla, Narra Naga Venkatesh, N. Srikantiya Indira   +7 more
openalex   +1 more source

Incidence of Carpal Tunnel Syndrome After the Diagnosis of Ulnar Neuropathy. [PDF]

J Hand Surg Glob Online
Fellheimer HS, DiDomenico E, Ayub M, Livingston M, Justice WL, Onor GI, Tecce E, Beredjiklian PK.   +7 more
europepmc   +1 more source

TrkA abundance is increased in cutaneous nerves in bortezomib‐induced neuropathy

Brain Pathology, EarlyView.
Cutaneous nerves in bortezomib‐induced peripheral neuropathy (BIPN) show reduced nerve fiber density, increased TrkA expression, and enhanced dermal angiogenesis, highlighting a pathological switch in NGF/TrkA signaling that may contribute to nerve damage and pain. Abstract Tropomyosin receptor kinase A (TrkA), a high‐affinity receptor for nerve growth
Yuying Jin, Nadine Cebulla, Daniel Schirmer, Eva Runau, Leon Flamm, Calvin Terhorst, Laura Jähnel, Johanna Güse, Nicola Giordani, Annett Wieser, Julian Brennecke, Annemarie Sodmann, Martin Kortüm, Robert Blum, Claudia Sommer   +14 more
wiley   +1 more source

Epidemiology, Patient Characteristics, Real-World Treatment Patterns, and Healthcare Utilization and Spending for Patients with Multifocal Motor Neuropathy: A US Claims-Based Analysis. [PDF]

J Health Econ Outcomes Res
Khandelwal N, Geremakis C, Riaz F, Ryan G, Saundankar V, Sheer R, Suehs B.   +6 more
europepmc   +1 more source

Repetitive after-discharges are more common in acquired demyelinating polyneuropathies. [PDF]

Sci Rep
Uzunçakmak-Uyanık H, Yıldız FG, Temuçin ÇM.   +2 more
europepmc   +1 more source